The safety, tolerability and pharmacokinetic profile of multiple doses of AD 452, a new once daily small molecule, broad spectrum anti-cytokine DMARD, in healthy male subjects.

被引：0

|

作者：

Mercer, A. J. ^{[1
]}

Baker, H. ^{[1
]}

Eltringham, E. ^{[1
]}

Febbraro, S. ^{[1
]}

Bakhtyari, A. ^{[1
]}

机构：

[1] Sosei R&D Ltd, Simbec Ltd, Saffron Walden, Essex, England

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 81卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：S36 / S36

页数：1

相关论文

共 3 条

[1] The safety, tolerability and pharmacokinetic profile of multiple doses of AD 452, a new once daily small molecule, broad spectrum anti-cytokine DMARD, in healthy male subjects
Mercer, A. J.
Baker, H.
Eltringham, E.
Febbraro, S.
Bakhtyari, A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S36 - S37
[2] Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Multiple-Doses of DRL-17822, a Potent Cholesteryl Ester Transfer Protein Inhibitor in Healthy Male Subjects
Dasari, Mallikarjuna Rao
Bapat, Abhijit
Vittal, Shivva
Tippana, Mangapathiraju
Hasham, Sumera
Sai, Sesha M.
Alikunju, Shanavas
Sadashivam, Vasu
Allenby, Kent
Kumar, Rajinder
CIRCULATION, 2010, 122 (21)
[3] The pharmacodynamic and pharmacokinetic profile, safety and tolerability of the new H1 anti-histamine, vapitadine (R129160; hivenyl™), after single and multiple oral doses in healthy volunteers.
Beetens, J.
Leempoels, J.
Van Osselaer, N.
Van Peer, A.
Vande-Plassche, L.
Cauwenbergh, G.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A78 - A78